Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version

被引：175

作者：

Kanti, V. ^{[1
,2
,3
,4
]}

Messenger, A. ^{[5
]}

Dobos, G. ^{[1
,2
,3
,4
]}

Reygagne, P. ^{[6
]}

Finner, A.

Blumeyer, A.

Trakatelli, M. ^{[7
]}

Tosti, A. ^{[8
]}

del Marmol, V. ^{[9
]}

Piraccini, B. M. ^{[10
]}

Nast, A. ^{[1
,2
,3
,11
]}

Blume-Peytavi, U. ^{[1
,2
,3
,4
]}

机构：

[1] Charite, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] Berlin Inst Hlth, Dept Dermatol & Allergy, Clin Res Ctr Hair & Skin Sci, Berlin, Germany

[5] Univ Sheffield, Dept Dermatol, Sheffield, S Yorkshire, England

[6] Hop St Louis, Ctr Sabouraud, Paris, France

[7] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Dermatol & Venerol, Thessaloniki, Greece

[8] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA

[9] Univ Libre Bruxelles, Hop Erasme, Dept Dermatol, Brussels, Belgium

[10] Univ Bologna, Dept Dermatol, Bologna, Italy

[11] Berlin Inst Hlth, Dept Dermatol & Allergy, Div Evidence Based Med, Berlin, Germany

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 01期

关键词：

PATTERN HAIR LOSS; FINASTERIDE; MG; 2-PERCENT TOPICAL MINOXIDIL; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CLINICAL-TRIAL; INCREASES ANAGEN HAIR; PLATELET-RICH PLASMA; DOUBLE-BLIND; 5-PERCENT MINOXIDIL; ORAL FINASTERIDE;

D O I：

10.1111/jdv.14624

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80% Caucasian men and 42% of women. Patients afflicted with androgenetic alopecia may undergo significant impairment of quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence-based guidelines for the treatment of androgenetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.

引用

页码：11 / 22

页数：12

共 133 条

[1]

ALANIS A, 1991, CURR THER RES CLIN E, V49, P723

[2] TOPICAL MINOXIDIL IN ANDROGENETIC ALOPECIA - SCANDINAVIAN AND MIDDLE-EAST EXPERIENCE [J].